In line with previous findings that BRAF mutation and CMS4 subtype are risk factors for PM21, our results similarly implicate mutations in the RTK-RAS and TGF-Beta pathways in promoting PM occurrence in CRC (Fig. 5a). This evidence concerns the gene BRAF and colorectal carcinoma.